These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28948567)

  • 21. Evaluation of hydroperoxides in common pharmaceutical excipients.
    Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
    J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior lactose glycation of caseinate via the Maillard reaction affects in vitro activities of the pepsin-trypsin digest toward intestinal epithelial cells.
    Wang XP; Zhao XH
    J Dairy Sci; 2017 Jul; 100(7):5125-5138. PubMed ID: 28456399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acid-Induced Gelation of Caseins Glycated with Lactose: Impact of Maillard Reaction-Based Glycoconjugation and Protein Cross-Linking.
    Hannß M; Hubbe N; Henle T
    J Agric Food Chem; 2018 Oct; 66(43):11477-11485. PubMed ID: 30295020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analytical study proving alprazolam degradation to its main impurity triazolaminoquinoleine through Maillard reaction.
    Huidobro AL; Barbas C
    Anal Bioanal Chem; 2009 Jul; 394(5):1349-59. PubMed ID: 19066862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of feasibility of maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre formulation studies.
    Monajjemzadeh F; Hassanzadeh D; Valizadeh H; Siahi-Shadbad MR; Mojarrad JS; Robertson T; Roberts MS
    AAPS PharmSciTech; 2009; 10(2):649-59. PubMed ID: 19455427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From single excipients to dual excipient platforms in dry powder inhaler products.
    Shur J; Price R; Lewis D; Young PM; Woollam G; Singh D; Edge S
    Int J Pharm; 2016 Dec; 514(2):374-383. PubMed ID: 27262269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The kinetics of Maillard reaction in lactose-hydrolysed milk powder and related systems containing carbohydrate mixtures.
    Naranjo GB; Pereyra Gonzales AS; Leiva GE; Malec LS
    Food Chem; 2013 Dec; 141(4):3790-5. PubMed ID: 23993550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Presence of excipients in pharmaceutical products in 3 sources of therapeutic information].
    Altimiras J; Nieto-Hernández T; Buitrago F
    Aten Primaria; 1996 Sep; 18(4):190-3. PubMed ID: 8963000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of protein bound Maillard reaction end-products and free Amadori compounds in low lactose milk in presence of fructosamine oxidase I.
    Troise AD; Buonanno M; Fiore A; Monti SM; Fogliano V
    Food Chem; 2016 Dec; 212():722-9. PubMed ID: 27374589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of chemical stability of sitagliptin by LC-UV, LC-MS and FT-IR methods.
    Gumieniczek A; Berecka A; Mroczek T; Wojtanowski K; Dąbrowska K; Stępień K
    J Pharm Biomed Anal; 2019 Feb; 164():789-807. PubMed ID: 30503802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maillard conjugation of lactulose with potentially bioactive peptides.
    Nooshkam M; Madadlou A
    Food Chem; 2016 Feb; 192():831-6. PubMed ID: 26304417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on new co-processed excipient consisting of lactose and gelatinized starch].
    Wang ST; Zhang J; Lin X; Shen L; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4329-34. PubMed ID: 25850261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compaction of lactose drug mixtures: quantification of the extent of incompatibility by FT-Raman spectroscopy.
    Flemming A; Picker-Freyer KM
    Eur J Pharm Biopharm; 2008 Mar; 68(3):802-10. PubMed ID: 17826048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of excipient interactions on solid dosage form stability.
    Narang AS; Desai D; Badawy S
    Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in the α and β anomer content of commercially available lactose.
    Altamimi MJ; Wolff K; Nokhodchi A; Martin GP; Royall PG
    Int J Pharm; 2019 Jan; 555():237-249. PubMed ID: 30395957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone.
    Costantino HR; Carrasquillo KG; Cordero RA; Mumenthaler M; Hsu CC; Griebenow K
    J Pharm Sci; 1998 Nov; 87(11):1412-20. PubMed ID: 9811499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using an enzymatic galactose assay to detect lactose glycation extents of two proteins caseinate and soybean protein isolate via the Maillard reaction.
    Wang XP; Zhao XH
    J Sci Food Agric; 2017 Jun; 97(8):2617-2622. PubMed ID: 27748509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of high shear blending on alpha-lactose monohydrate.
    Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
    Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.